| Term 
 
        | Mechanism of action for Angiovist 370 •Contrast agent
 |  | Definition 
 
        | •Radiopaque contrast media •Clear colorless solution that absorbs x-rays
 •370 mg of iodine per ml
 •0.15 mEq of sodium per ml
 |  | 
        |  | 
        
        | Term 
 
        | Indications for Angiovist 370 •Contrast agent
 |  | Definition 
 
        | •Selective coronary angiography •Ventricular radiography
 •Pulmonary angiography
 |  | 
        |  | 
        
        | Term 
 
        | Mechanism of action for Isovue 370 •Contrast agent
 |  | Definition 
 
        | •Nonionic radiopaque contrast media •Clear colorless solution that absorbs xrays
 •0.002 mEq of iodine per ml
 |  | 
        |  | 
        
        | Term 
 
        | Indications for Isovue 370 •Contrast agent
 |  | Definition 
 
        | •Selective coronary angiography •Ventricular radiography
 •Pulmonary angiography
 •Patients with history of severe adverse reaction to ionic contrast
 •Patients with fluid overload
 |  | 
        |  | 
        
        | Term 
 
        | Mechanism of action for Iodixonal Injection (Visipaque 320) •Contrast agent
 |  | Definition 
 
        | •Iso-osmolar, nonionic, water-soluble radiographic contrast medium •Contains 320 mg/ml of iodine
 •Contains 0.044 mg calcium chloride dehydrate per ml and 1.11 mg sodium chloride per ml, providing for both concentrations at a sodium/ calcium ratio equivalent to blood
 •Iodine plasma levels peak immediately after rapid intravascular injection and fall rapidly within 5 to 10 minutes (due to dilution in vascular and extravascular fluid compartments).
 •Excreted via the kidneys 97% unchanged
 |  | 
        |  | 
        
        | Term 
 
        | Indications for Iodixonal Injection (Visipaque 320) •Contrast agent
 |  | Definition 
 
        | •Cardiac angiography •Left ventriculography
 •Aortography
 •Peripheral arteriography
 •Cerebral and visceral arteriography
 |  | 
        |  | 
        
        | Term 
 
        | Mechanisms of action for Iohexol Injection (Omnipaque 350) •Contrast agent
 |  | Definition 
 
        | •Non-ionic, water-soluble radiographic contrast medium •Contains 755 mg of iohexol equivalent to 350 mg of organic iodine per ml
 •Excreted unchanged by the kidneys
 |  | 
        |  | 
        
        | Term 
 
        | Indications for Iohexol Injection (Omnipaque 350) •Contrast agent
 |  | Definition 
 
        | •Cardiac angiography •Left ventriculography
 •Aortography
 •Peripheral arteriography
 •Cerebral and visceral arteriography
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Iohexol Injection (Omnipaque 350) •Contrast agent
 |  | Definition 
 
        | •Right coronary artery: 3 to 8 ml •Left coronary artery: 3 to 10 ml
 •Left ventriculography: 30 to 60 ml
 •Renal arteriography: 8 to 18 ml
 •Aortography: 30 to 70 ml
 •Pulmonary arteriography: 1 ml/kg
 •Not to usually exceed 200 to 250 ml
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Iohexol Injection (Omnipaque 350) •Contrast agent
 |  | Definition 
 
        | •Right coronary artery: 3 to 8 ml •Left coronary artery: 3 to 10 ml
 •Left ventriculography: 30 to 60 ml
 •Renal arteriography: 8 to 18 ml
 •Aortography: 30 to 70 ml
 •Not to usually exceed 200 to 250 ml
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Isovue 370 •Contrast agent
 |  | Definition 
 
        | •4 - 10 mls per coronary artery injection •35 - 50 mls for gram
 •15 - 40 mls for AO root grams
 •Max dose per procedure 3 ml/kg
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Angiovist 370 •Contrast agent
 |  | Definition 
 
        | •4 - 10 mls per coronary artery injection •35 - 50 mls for gram
 •15 - 40 mls for AO root grams
 •Max dose per procedure 3 ml/kg
 |  | 
        |  |